Sionna Therapeutics, Inc.
SION
$17.35
$1.519.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 104.68% | 43.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 49.53% | 43.97% | |||
| Operating Income | -49.53% | -43.97% | |||
| Income Before Tax | -39.12% | -33.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -39.12% | -33.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.12% | -33.45% | |||
| EBIT | -49.53% | -43.97% | |||
| EBITDA | -50.22% | -44.49% | |||
| EPS Basic | 83.87% | 13.82% | |||
| Normalized Basic EPS | 83.88% | 13.82% | |||
| EPS Diluted | 83.87% | 13.82% | |||
| Normalized Diluted EPS | 83.88% | 13.82% | |||
| Average Basic Shares Outstanding | 762.78% | 54.85% | |||
| Average Diluted Shares Outstanding | 762.78% | 54.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||